Single-cell RNA-seq reveals abnormal differentiation of keratinocytes and increased inflammatory differentiated keratinocytes in atopic dermatitis
- PMID: 37326015
- DOI: 10.1111/jdv.19256
Single-cell RNA-seq reveals abnormal differentiation of keratinocytes and increased inflammatory differentiated keratinocytes in atopic dermatitis
Abstract
Background: Atopic dermatitis (AD) is a chronic and recurrent inflammatory skin disease characterized by severe pruritus and eczematous lesions. Heterogeneity of AD has been reported among different racial groups according to clinical, molecular and genetic differences.
Objective: This study aimed to conduct an in-depth transcriptome analysis of AD in Chinese population.
Methods: We performed single-cell RNA sequencing (scRNA-seq) analysis of skin biopsies from five Chinese adult patients with chronic AD and from four healthy controls, combined with multiplexed immunohistochemical analysis in whole-tissue skin biopsies. We explored the functions of IL19 in vitro.
Results: ScRNA-seq analysis was able to profile a total of 87,853 cells, with keratinocytes (KCs) in AD manifesting highly expressed keratinocyte activation and pro-inflammatory genes. KCs demonstrated a novel IL19+ IGFL1+ subpopulation that increased in AD lesions. Inflammatory cytokines IFNG, IL13, IL26 and IL22 were highly expressed in AD lesions. In vitro, IL19 directly downregulated KRT10 and LOR in HaCaT cells and activated HaCaT cells to produce TSLP.
Conclusion: Abnormal proliferation and differentiation of keratinocytes contribute immensely to the pathogenesis of AD, whereas AD chronic lesions have witnessed significant presence of IL19+ IGFL1+ KCs, which may be involved in the disruption of the skin barrier, the connection and magnification of Th2 and Th17 inflammatory responses, and mediation of skin pruritus. Furthermore, progressive activation of multiple immune axes dominated by Type 2 inflammatory reaction occur in AD chronic lesions.
© 2023 European Academy of Dermatology and Venereology.
References
REFERENCES
-
- Hulpusch C, Weins AB, Traidl-Hoffmann C, Reiger M. A new era of atopic eczema research: advances and highlights. Allergy. 2021;76:3408-21.
-
- Nomura T, Kabashima K. Advances in atopic dermatitis in 2019-2020: endotypes from skin barrier, ethnicity, properties of antigen, cytokine profiles, microbiome, and engagement of immune cells. J Allergy Clin Immunol. 2021;148:1451-62.
-
- Navrazhina K, Renert-Yuval Y, Frew JW, Grand D, Gonzalez J, Williams SC, et al. Large-scale serum analysis identifies unique systemic biomarkers in psoriasis and hidradenitis suppurativa. Br J Dermatol. 2021;186:684-93.
-
- Reynolds G, Vegh P, Fletcher J, Poyner E, Stephenson E, Goh I, et al. Developmental cell programs are co-opted in inflammatory skin disease. Science. 2021;371:eaba6500.
-
- Shamji MH, Temblay JN, Cheng W, Byrne SM, Macfarlane E, Switzer AR, et al. Antiapoptotic serine protease inhibitors contribute to survival of allergenic TH2 cells. J Allergy Clin Immunol. 2018;142:569-81.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous